Mattila Jyrki 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Mar 19, 2018
Insider Transaction Report
Form 4
Mattila Jyrki
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-03-15+15,000→ 15,000 totalExercise: $41.82Exp: 2028-03-15→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The options were granted on March 15, 2018, and will vest in four equal annual installments beginning on the first anniversary of the grant date.